Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injection in Pregnant Women With Type 2 Diabetes: A Single-center Open Label Randomized Controlled Trial

NCT05001815 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT05001815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05001815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injection in Pregnant Women With Type 2 Diabetes: A Single-center Open Label Randomized Controlled Trial
Lead sponsor
Peking University Third Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 15, 2021
Completion date
October 1, 2023
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy in diabetic, type 2 diabetes